rs2651899 — PRDM16

Intronic variant in the master regulator of brown/beige fat differentiation, GWAS-validated for migraine risk and linked to impaired thermogenesis and blood pressure regulation

See your personal result for PRDM16

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

PRDM16 — Where Migraine Meets Metabolic Fire

PRDM16 (PR/SET Domain 16) is best known as the master transcription factor that drives brown and beige fat cell differentiation — the type of fat that burns calories to produce heat rather than storing them. But a landmark genome-wide association study unexpectedly placed this metabolic gene at the center of migraine biology, revealing a surprising link between thermogenic fat regulation and headache susceptibility.

The Mechanism

The rs2651899 variant sits within the first intron of PRDM16 in a region of moderate linkage disequilibrium11 linkage disequilibrium
LD — the tendency of nearby genetic variants to be inherited together because they sit close on the same chromosome extending roughly 22 kb in each direction. While intronic, this region likely harbors regulatory elements that influence PRDM16 expression levels. PRDM16 protein acts as a transcriptional switch: it activates the thermogenic gene program (including UCP1) in adipocytes and simultaneously represses white fat and smooth muscle gene programs. In the vascular system, PRDM16 maintains beige adipocyte identity in perivascular fat — the fat cushion surrounding blood vessels that modulates vascular tone.

The migraine connection, while not fully resolved, likely involves PRDM16's role in neurovascular regulation. A 2026 study in Science22 2026 study in Science
Cohen et al. Ablation of Prdm16 and beige fat identity causes vascular remodeling and elevated blood pressure demonstrated that when PRDM16 is lost in adipocytes, beige fat converts to dysfunctional white fat that overproduces the enzyme QSOX133 QSOX1
Quiescin sulfhydryl oxidase 1 — an enzyme that promotes collagen cross-linking and tissue fibrosis, triggering vascular fibrosis, increased vascular reactivity, and hypertension. In human cohorts, carriers of PRDM16 mutations showed elevated blood pressure, confirming the mouse findings translate to human biology.

The Evidence

The original GWAS44 original GWAS
Chasman et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet, 2011 analyzed 5,122 migraineurs and 18,108 controls from the Women's Genome Health Study, identifying rs2651899 with an odds ratio of 1.11 (95% CI 1.07-1.15, p = 3.8 x 10⁻⁹) — reaching genome-wide significance. This was replicated across three independent cohorts totaling 3,828 additional migraineurs.

A meta-analysis of eight studies55 meta-analysis of eight studies
Kowalska et al. Deciphering the role of rs2651899, rs10166942, and rs11172113 polymorphisms in migraine. Medicina, 2022 including 2,320 migraine patients and 2,615 controls found the CC genotype associated with overall migraine risk (OR = 1.32, 95% CI 1.02-1.73) and a stronger effect for migraine with aura (OR = 1.40, 95% CI 1.12-1.74, p = 0.003). A separate meta-analysis66 separate meta-analysis
Lee et al. Association of rs2651899 polymorphism in PRDM16 and common migraine subtypes. Headache, 2020 of six studies with 2,853 cases confirmed the recessive model (CC vs CT+TT) showed OR = 1.42 for migraine.

Replication studies in Chinese77 Chinese
Zhao et al. PRDM16 rs2651899 variant is a risk factor for Chinese common migraine patients, Indian88 Indian, and Pakistani99 Pakistani populations have confirmed the association, though with varying effect sizes and migraine subtypes.

Practical Actions

The dual nature of PRDM16 — governing both thermogenic fat and neurovascular function — opens two avenues of action. For migraine susceptibility, mitochondrial-supporting supplements have strong evidence from randomized controlled trials: riboflavin (vitamin B2) at 400 mg/day reduced migraine frequency1010 reduced migraine frequency
Schoenen et al. Effectiveness of high-dose riboflavin in migraine prophylaxis. Neurology, 1998 by 50% or more in 59% of treated patients (NNT = 2.3), while CoQ10 supplementation1111 CoQ10 supplementation
Sazali et al. Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine. BMJ Open, 2021 reduced attack frequency and duration in meta-analysis. Magnesium (400-600 mg/day as glycinate or threonate) earned a Level B recommendation from the American Headache Society for migraine prevention.

For the thermogenic side, cold exposure protocols (cold showers, outdoor cold exposure) directly stimulate PRDM16-dependent beige fat activation and may help compensate for reduced PRDM16 activity by upregulating thermogenic pathways through sympathetic nervous system signaling.

Interactions

PRDM16 rs2651899 was discovered alongside TRPM8 rs10166942 (a cold-sensing ion channel) in the same migraine GWAS, representing two branches of thermosensory-neurovascular vulnerability. PRDM16 also sits upstream in the same thermogenic cascade as UCP1 (rs1800592) and ADRB3 (rs4994) — variants that independently impair brown/beige fat function. Carrying risk alleles across multiple thermogenic pathway genes could compound both metabolic and neurovascular effects, though direct interaction studies for rs2651899 with these SNPs have not yet been published.

Nutrient Interactions

riboflavin increased_need
coenzyme Q10 increased_need
magnesium increased_need

Genotype Interpretations

What each possible genotype means for this variant.

TT Full Thermogenic Function Normal

Reference genotype — normal PRDM16 regulation

You carry the reference genotype at rs2651899, which is associated with normal PRDM16 regulatory activity. About 33% of Europeans and 10% of people of African descent share this genotype. Your PRDM16-driven brown and beige fat differentiation pathways operate without this particular genetic influence on migraine susceptibility or thermogenic regulation.

CT Reduced Thermogenic Drive Intermediate

One risk allele — mildly elevated migraine susceptibility and modestly reduced thermogenic signaling

PRDM16 sits at the intersection of two biological systems: thermogenic adipocyte differentiation and neurovascular regulation. The C allele at rs2651899 is in a regulatory region of intron 1 that likely modulates PRDM16 expression. With one copy, you have partially reduced regulatory drive at this locus. A 2026 Science paper showed that reduced PRDM16 activity leads to loss of beige fat identity, overproduction of the enzyme QSOX1, vascular fibrosis, and elevated blood pressure — and human carriers of PRDM16 mutations confirmed elevated blood pressure in clinical cohorts.

For migraine, the heterozygous effect is modest but replicated across multiple populations. Mitochondrial-supporting supplements (riboflavin, CoQ10, magnesium) have strong RCT evidence for migraine prophylaxis regardless of genotype, but they are particularly relevant for carriers of thermogenic pathway variants where mitochondrial function may be subtly impaired.

CC Impaired Thermogenic Drive High Risk

Two risk alleles — elevated migraine risk and reduced thermogenic fat activation

With two C alleles, you have the maximum genetic influence from this locus on PRDM16 regulation. PRDM16 is the master switch for brown and beige adipocyte differentiation — the specialized fat cells that burn calories to generate heat. A landmark 2026 study in Science showed that ablation of PRDM16 in adipocytes causes beige fat to lose its identity and overproduce QSOX1, an enzyme that triggers vascular fibrosis and heightened sensitivity to angiotensin II (the blood-pressure-raising hormone). Human carriers of PRDM16 mutations showed significantly higher blood pressure in large clinical cohorts.

The migraine association is robust across populations. The Kowalska et al. meta-analysis (8 studies, 4,935 subjects) found OR = 1.40 for migraine with aura specifically in CC carriers. The Lee et al. meta-analysis (6 studies, 12,172 subjects) confirmed OR = 1.42 under a recessive model. Both analyses suggest the CC genotype carries disproportionate risk compared to CT.

The biological plausibility is strong: PRDM16 dysfunction impairs vascular tone regulation via perivascular adipose tissue, and migraine is fundamentally a neurovascular disorder. The evidence connecting this specific SNP to altered PRDM16 protein levels or activity is still being established, but the GWAS signal is genome-wide significant and well-replicated.